Uncertainty of Successive Existential Risks of Case-effect Type Economic Pandemia and Crisis, in Progress of Activities in the Pharmaceutical Industry

Uncertainty and risk can be seen as interdisciplinary phenomena. At the same time, the uncertainty and the risk of the rule are taken into account in the context of the analysis of decisionmaking processes. Under uncertainty and risk, an enterprise needs to have a rational basis for decision-making that allows the comparison of different alternatives and the choice of the most appropriate operating strategy in the management of pharmaceutical companies In today's economy, with the growth of information flows, there is an objective need to continuously increase employees' skills, an increase in the number of modernization projects, which will reduce labor and material consumption, the development of industrial marketing tools and increased operational efficiency. The pharmaceutical industry needs flexibility like no other industry, which will make rapid reconstruction possible. The purpose of this paper is to identify the importance of digitization for the pharmaceutical industry.